Alterations in the gyrA and parC Genes in Salmonella spp. Following In Vitro Exposure to Fluoroquinolones

References

• Parry CM. Antimicrobial drug resistance in Salmonella enterica. Curr Opin Infect Dis 2003; 16 (5): 467–72.
   PubMed Web of Science ®Google Scholar
• Hernandez T, Rodriguez-Alvarez C, Arevalo MP, Torres A, Sierra A, Arias A. Antimicrobial-resistant Salmonella enter-ica serovars isolated from chickens in Spain. J Chemother 2002; 14 (4): 346–50.
   PubMed Web of Science ®Google Scholar
• Dobardzic R, Dobardzic A. The minimum inhibitory con-centration of seventeen antimicrobials for Salmonella isolates from septic patients. J Chemother 1996; 8 (5): 369–74.
   PubMed Web of Science ®Google Scholar
• Cullmann W. Comparative evaluation of orally active antibiotics against community-acquired pathogens: a multi-cen-ter study in five Mediterranean countries. J Chemother 1995; 7 (1): 21–5.
   PubMed Web of Science ®Google Scholar
• Threlfall EJ, Fisher IS, Berghold C, et al. Antimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: results of inter-national multi-centre surveillance. Euro Surveill 2003; 8 (2): 41–5.
   PubMedGoogle Scholar
• Cebrian L, Sirvent E, Rodriguez JC, Ruiz M, Royo G. Characterisation of Salmonella spp. mutants produced by exposure to various fluoroquinolones. Int J Antimicrob Agents 2003; 22 (2): 134–9.
   PubMed Web of Science ®Google Scholar
• Griggs DJ, Gensberg K, Piddock LJV. Mutations in gyrA gene of Quinolone-resistant Salmonella serotypes isolat-ed from humans and animals. Antimicrob Agents Chemother 1996; 40: 1009–13.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards (NCCLS). Performance standars for antimicrobial susceptibility testing; tenth informational supplement (aerobic dilution) M100-S10 (M7). NCCLS. 2000. Wayne, PA.
   Google Scholar
• Mesa Espanola de NormalizaciOn de la Sensibilidad y Resistencia a los Antimicrobianos (MENSURA). Recomendaciones del grupo MENSURA para la selecciOn de antimicrobianos en el estudio de la sensibilidad y criterios para La interpretacinn del antibiograma. Rev Esp Quimioter 2000; 13: 73–6.
   Google Scholar
• Delsol AA, Woodward MJ, Roe JM. Effect of a 5 day enrofloxacin treatment on Salmonella enterica serotype Typhimurium DT104 in the pig. J Antimicrob Chemother. 2004; 53 (2): 396–8.
   PubMed Web of Science ®Google Scholar
• Giraud E, Cloeckaert A, Kerboeuf D, Chaslus-Dancla E. Evidence for active efflux as the primary mechanism of resis-tance to ciprofloxacin in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 2000; 44 (5): 1223–8.
   PubMed Web of Science ®Google Scholar
• Soto SM, Ruiz J, Mendoza MC, Vila J. In vitro fluoro-quinolone-resistant mutants of Salmonella enterica serotype Enteritidis: analysis of mechanisms involved in resistance. Int J Antimicrob Agents 2003; 22 (5): 537–40.
   PubMed Web of Science ®Google Scholar
• Ling JM, Chan EW, Lam AW, Cheng AF. Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong. Antimicrob Agents Chemother. 2003; 47 (11): 3567–73.
   PubMed Web of Science ®Google Scholar
• Giraud E, Cloeckaert A, Baucheron S, Mouline C, Chaslus-Dancla E.J. Fitness cost of fluoroquinolone resistance in Salmonella enterica serovar Typhimurium. J Med Microbiol 2003;52(Pt 8):697–703.
   PubMed Web of Science ®Google Scholar
• Liebana E, Clouting C, Cassar CA, et al. Comparison of gyrA mutations, cyclohexane resistance, and the presence of class I integrons in Salmonella enterica from farm animals in England and Wales. J Clin Microbiol 2002; 40 (4): 1481–6.
   PubMed Web of Science ®Google Scholar
• Vasallo FJ, Martin-Rabadan P, Alcala L, Garcia-Lechuz JM, Rodriguez-Creixems M, Bouza E. Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis. Clin Infect Dis 1998; 26 (2): 535–6.
   PubMed Web of Science ®Google Scholar
• Crump JA, Barrett TJ, Nelson JT, Angulo FJ. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. Clin Infect Dis 2003; 37 (1): 75–81.
   PubMed Web of Science ®Google Scholar
• Aarestrup FM, Wiuff C, Molbak K, Threlfall EJ. Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob Agents Chemother 2003; 47 (2): 827-9.
   Google Scholar
• McEwen SA, Fedorka-Cray PJ. Antimicrobial use and resistance in animals. Clin Infect Dis 2002;34(Suppl 3):593–S106.
   Google Scholar
• Angulo FJ, Johnson KR, Tauxe RV, Cohen ML. Origins and consequences of antimicrobial-resistant nonty-phoidal Salmonella: implications for the use of fluoro-quinolones in food animals. Microb Drug Resist 2000; 6 (1): 77–83.
   PubMed Web of Science ®Google Scholar
• Witte W. Ecological impact of antibiotic use in animals on different complex microflora: environment. Int J Antimicrob Agents 2000; 14 (4): 321–5.
   PubMed Web of Science ®Google Scholar
• Phillips I, Casewell M, Cox T, et al. Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. J Antimicrob Chemother 2004; 53 (1): 28–52.
   PubMed Web of Science ®Google Scholar
• Glynn MK, Reddy V, Hutwagner L, et al. Prior antimi-crobial agent use increases the risk of sporadic infections with multidrug-resistant Salmonella enterica serotypeTyphimurium: a FoodNet case-control study, 1996-1997. Clin Infect Dis 2004;38(Suppl 3):S227–36.
   PubMed Web of Science ®Google Scholar
• Voltersvik P, Halstensen A, Langeland N, et al. Eradication of non-typhoid salmonellae in acute enteritis after therapy with ofloxacin for 5 or 10 days. J Antimicrob Chemother 2000; 46 (3): 457–9.
   PubMed Web of Science ®Google Scholar
• Barbara G, Stanghellini V, Berti-Ceroni C, et al. Role of antibiotic therapy on long-term germ excretion in faeces and digestive symptoms after Salmonella infection. Aliment Pharmacol Ther 2000; 14 (9): 1127–31.
   PubMed Web of Science ®Google Scholar